跳至主要内容
临床试验/NCT01565343
NCT01565343已完成1 期

Test-retest Reproducibility of 18F-AV-45 for Brain Imaging of Amyloid in Healthy Volunteers and Alzheimer's Disease Patients

Avid Radiopharmaceuticals1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2008年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Mean Cortical to Cerebellum SUVR

研究概览

简要总结

This study will test if two AV-45 PET scans up to 4 weeks apart in AD subjects and healthy volunteers provide the same results. The study will also test two different AV-45 injection methods in a small subgroup of enrolled AD subjects (slow vs. fast bolus group).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
35 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

AD Subjects

Experimental

Two bolus IV injections followed by brain PET scan up to 4 weeks apart

干预措施: florbetapir F 18 (Drug)

AD Subjects: Slow vs. Fast Bolus

Experimental

Two bolus IV injections followed by a brain PET scan up to 4 weeks apart.

The first injection given as a rapid bolus (< 5 second injection, with immediate flush). The second injection given as a slow bolus (approximately 20 to 30 second injection with a flush delayed by 10 seconds after dose administration).

干预措施: florbetapir F 18 (Drug)

Healthy controls

Experimental

Healthy male or female subjects; 35-55 years old. Two bolus IV injections followed by brain PET scan up to 4 weeks apart

干预措施: florbetapir F 18 (Drug)

结局指标

主要结局

Mean Cortical to Cerebellum SUVR

时间窗: 50-70 min after injection

Standardized Uptake Value ratio (SUVR) is the ratio of tracer uptake in predefined cortical regions, relative to uptake in the whole cerebellum.

次要结局

未报告次要终点

研究者

发起方
Avid Radiopharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验